Active Ingredient(s): Pyridostigmine
FDA Approved: * August 14, 1973
Pharm Company: * SANDOZ
Category: Myasthenic Syndrome

Pyridostigmine is a medication used to treat myasthenia gravis[1] and underactive bladder.[2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type.[3] It is typically given by mouth but can also be used by injection.[3] The effects generally begin within 45 minutes and last up to 6 hours.[3] Common side effects include nausea, diarrhea, frequen... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Regonol 5 mg/ml Intravenous; Parenteral Injection, Solution
NDC: 0781-3040
Sandoz Inc

Related Brands

Drugs with the same active ingredients